- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT07925099
Lateral Femoral Cutaneous Nerve Block (LFCN) in ACL Reconstruction With MacFL-type Lateral Tenodesis (RECUP- NCLC)
The goal of this randomized clinical trial is to evaluate whether adding an ultrasound-guided lateral femoral cutaneous nerve (LFCN) block to a standard regional analgesia protocol improves postoperative recovery in patients undergoing anterior cruciate ligament (ACL) reconstruction combined with MacIntosh-type lateral extra-articular tenodesis.
The main question the study aims to answer is whether adding an LFCN block to an adductor canal block (ACB) and an iPACK block improves the quality of postoperative recovery, as measured by the Quality of Recovery-15 (QoR-15) score at 24 hours after surgery.
The study will also assess:
- Preservation of quadriceps function, assessed by the ability to perform a straight leg raise (SLR).
- Postoperative pain at the lateral thigh graft harvest site and knee, at rest and during mobilization.
- Cumulative oral opioid consumption during the first 48 hours after surgery.
- Incidence of postoperative nausea and vomiting (PONV).
- Time to first postoperative ambulation.
- Patient satisfaction with analgesic management.
Adverse events and complications related to regional anesthesia, including sensory disturbances, hematoma, infection, and signs of local anesthetic systemic toxicity.
Participants will be randomly assigned in a 1:1 ratio to one of two treatment groups. All participants will undergo ACL reconstruction combined with MacIntosh-type lateral extra-articular tenodesis and will receive an ACB and an iPACK block. Participants in the experimental group will additionally receive an ultrasound-guided LFCN block.
Postoperative assessments will include QoR-15, pain scores, opioid consumption, PONV, quadriceps function, ambulation, patient satisfaction, and safety assessments during the first 48 hours after surgery and at 1 month. The primary outcome will compare the QoR-15 score at 24 hours between the two groups, with an 8-point difference considered clinically meaningful.
Обзор исследования
Статус
Тип исследования
Регистрация (Оцененный)
Фаза
- Непригодный
Контакты и местонахождение
Контакты исследования
- Имя: Yoann ELMALEH
- Номер телефона: +33 07 81 33 04 31
- Электронная почта: yoann.d.elmaleh@gmail.com
Места учебы
-
-
-
Quincy-sous-Sénart, Франция
- Hôpital Privé Claude Galien
-
Контакт:
- Yoan Elmaleh
- Номер телефона: +33 7 81 33 04 31
- Электронная почта: yoann.d.elmaleh@gmail.com
-
Évry, Франция
- Clinique du Mousseau
-
Контакт:
- Karim Guessous
- Номер телефона: +33 6 51 99 54 38
- Электронная почта: k.guessous@quincyanesthesie.com
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria:
- Adult patients aged 18 to 60 years;
- Presenting a primary anterior cruciate ligament (ACL) tear;
- Scheduled for ACL reconstruction associated with MacIntosh-type lateral extra-articular tenodesis (or equivalent technical variant using an iliotibial band 'ITB' graft);
- Surgery to be performed under general anesthesia;
- Planned management in outpatient surgery or short-stay hospitalization after the operation;
- Understanding the validated French version of the QoR-15 questionnaire;
- Having given their informed consent to participate in the study;
- Patients affiliated with or benefiting from a social security scheme.
Exclusion Criteria:
- Patients having allergy to local anesthetics or a contraindication to peripheral nerve blocks;
- Patients having neuropathy of the lower limbs;
- Patients having coagulation disorders or on major anticoagulation;
- Patients suffering from chronic pain that requires more than 30 mg morphine-equivalents per day;
- Patients undergoing revision ACL reconstruction;
- Patients with pre-existing hypoesthesia of the lateral thigh (e.g. known meralgia paresthetica);
- Patients unable to complete the questionnaires or expressing refusal to participate;
- Pregnant women, women of childbearing age without effective contraception), or women breastfeeding;
- Protected adults under guardianship, curatorship or other legal protection, deprived of liberty or under guardianship or curatorship, or unable to give consent.
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Уход
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Одинокий
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: ACB + iPACK + LFCN Block
Participants will undergo anterior cruciate ligament reconstruction combined with MacIntosh-type lateral extra-articular tenodesis. They will receive an adductor canal block (ACB) and an iPACK block as the standard regional analgesia protocol, with the addition of an ultrasound-guided lateral femoral cutaneous nerve (LFCN) block. |
Ultrasound-guided adductor canal block administered as part of the standard regional analgesia protocol for ACL reconstruction with MacIntosh-type lateral extra-articular tenodesis. Ultrasound-guided iPACK block (infiltration between the popliteal artery and the posterior capsule of the knee) administered as part of the standard regional analgesia protocol. Ultrasound-guided lateral femoral cutaneous nerve (LFCN) block administered in addition to the adductor canal block and iPACK block in the experimental arm. |
|
Активный компаратор: ACB + iPACK
Participants will undergo anterior cruciate ligament reconstruction combined with MacIntosh-type lateral extra-articular tenodesis. They will receive an adductor canal block (ACB) and an iPACK block without an additional lateral femoral cutaneous nerve (LFCN) block. |
Ultrasound-guided adductor canal block administered as part of the standard regional analgesia protocol for ACL reconstruction with MacIntosh-type lateral extra-articular tenodesis. Ultrasound-guided iPACK block (infiltration between the popliteal artery and the posterior capsule of the knee) administered as part of the standard regional analgesia protocol. |
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Quality of Recovery (QoR-15) Score
Временное ограничение: 24 hours after surgery
|
The quality of postoperative recovery will be assessed using the Quality of Recovery-15 (QoR-15) questionnaire. The QoR-15 score ranges from 0 to 150, with higher scores indicating better quality of recovery. The score will be assessed preoperatively before administration of regional anesthesia and again 24 hours after surgery. The primary analysis will compare the QoR-15 score at 24 hours between the experimental and active comparator groups. An 8-point difference between groups is considered the minimal clinically important difference. |
24 hours after surgery
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Preservation of Quadriceps Function
Временное ограничение: 24 hours after surgery
|
Quadriceps function will be assessed by the ability to perform a straight leg raise (SLR) at 24 hours postoperatively. |
24 hours after surgery
|
|
Postoperative Lateral Thigh and Knee Pain
Временное ограничение: 6, 24, and 48 hours after surgery
|
Pain intensity at the lateral thigh graft harvest site and knee will be assessed at rest and during mobilization using the Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst pain imaginable). |
6, 24, and 48 hours after surgery
|
|
Cumulative Postoperative Opioid Consumption
Временное ограничение: Day 0, Day 1, and Day 2 after surgery
|
Total oral opioid consumption will be recorded and converted to morphine milligram equivalents (MME). |
Day 0, Day 1, and Day 2 after surgery
|
|
Postoperative Nausea and Vomiting
Временное ограничение: Day 0, Day 1, and Day 2 after surgery
|
The incidence of postoperative nausea and vomiting (PONV) will be recorded during the postoperative period. |
Day 0, Day 1, and Day 2 after surgery
|
|
Time to First Postoperative Ambulation
Временное ограничение: Day 1 after surgery
|
Time from surgery to first postoperative ambulation will be recorded in hours. |
Day 1 after surgery
|
|
Patient Satisfaction With Analgesic Management
Временное ограничение: Day 1 and Day 2 after surgery
|
Patient satisfaction with postoperative analgesic management will be assessed using a 5-point Likert scale. |
Day 1 and Day 2 after surgery
|
|
Safety and Adverse Events Related to Regional Anesthesia
Временное ограничение: Day 1 and 1 month after surgery
|
Adverse events and complications potentially related to regional anesthesia will be recorded, including hypoesthesia or paresthesia of the lateral thigh, abnormal sensory disturbances, hematoma at the LFCN block site, infection, and signs of local anesthetic systemic toxicity. |
Day 1 and 1 month after surgery
|
Соавторы и исследователи
Следователи
- Главный следователь: Yoann ELMALEH, Hôpital Privé Claude Galien
Публикации и полезные ссылки
Общие публикации
- Leger M, Campfort M, Cayla C, Parot-Schinkel E, Lasocki S, Rineau E. Validation of an alternative French version of the Quality of Recovery-15 Score: the FQoR-15. Br J Anaesth. 2020 Oct;125(4):e345-e347. doi: 10.1016/j.bja.2020.05.052. Epub 2020 Jul 9. No abstract available.
- Myles PS, Myles DB, Galagher W, Chew C, MacDonald N, Dennis A. Minimal Clinically Important Difference for Three Quality of Recovery Scales. Anesthesiology. 2016 Jul;125(1):39-45. doi: 10.1097/ALN.0000000000001158.
- Demumieux F, Ludes PO, Diemunsch P, Bennett-Guerrero E, Lujic M, Lefebvre F, Noll E. Validation of the translated Quality of Recovery-15 questionnaire in a French-speaking population. Br J Anaesth. 2020 Jun;124(6):761-767. doi: 10.1016/j.bja.2020.03.011. Epub 2020 Apr 15.
- Nakase J, Shimozaki K, Asai K, Yoshimizu R, Kimura M, Tsuchiya H. Usefulness of lateral femoral cutaneous nerve block in combination with femoral nerve block for anterior cruciate ligament reconstruction: a prospective trial. Arch Orthop Trauma Surg. 2021 Mar;141(3):455-460. doi: 10.1007/s00402-020-03724-9. Epub 2021 Jan 2.
- Le Bescond V, Petit-Phan J, Campfort M, Nicolleau C, Conte M, Bouhours G, Rony L, Lasocki S, Leger M. Validation of the postoperative Quality of Recovery-15 questionnaire after emergency surgery and association with quality of life at three months. Can J Anaesth. 2024 May;71(5):590-599. doi: 10.1007/s12630-024-02722-4. Epub 2024 Mar 19.
- Garg DR, Li D, Bordoni B. Anatomy, Bony Pelvis and Lower Limb: Lateral Femoral Cutaneous Nerve. 2026 Feb 15. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK532301/
- Wascher DC, Lording TD, Neyret P. Extra-articular procedures for the ACL-deficient knee: a state of the art review. Journal of ISAKOS. mai 2016;1(3):174-82. doi:10.1136/jisakos-2016-000053
- Uddin I, Chazapis M. Obturator nerve block [Internet]. World Federation of Societies of Anaesthesiologists; juin 2024 [cité 4 févr 2026]. Disponible https://resources.wfsahq.org/atotw/obturator-nerve-block/ doi:10.28923/atotw.525
Даты записи исследования
Изучение основных дат
Начало исследования (Оцененный)
Первичное завершение (Оцененный)
Завершение исследования (Оцененный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- COS-RGDS-2025-12-027-P-ELMALEH
- 2026-A01042-49 (Другой идентификатор: ID-RCB)
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .